Digital Health (Digital Therapeutic, Monitoring and Diagnostic Solutions) Market, 2030

Dublin, Sept. 05, 2018 (GLOBE NEWSWIRE) -- The "Digital Health Market: Focus on Digital Therapeutic, Monitoring and Diagnostic Solutions, 2018-2030" report has been added to ResearchAndMarkets.com's offering.

The Digital Health Market: Focus on Digital Therapeutic, Monitoring & Diagnostic Solutions, 2018-2030' report features an extensive study of the current landscape and future outlook of the growing market for digital therapeutics, monitoring and diagnostic solutions that are either commercialized or under development within the healthcare industry. This burgeoning field presently offers a lot of opportunities to innovation focused start-ups and investors.

Digital healthcare, a relatively new concept that emerged only a few years ago, is believed to possess the potential to address the rising concerns related to the growing socio-economic burden. Driven by the demand for self-management approaches, personalized healthcare solutions and customized treatment regimens made available in the home-care setting, digital health companies are presently engaged in developing several innovative solutions for therapeutic, surveillance and diagnostic use.

Various digital therapeutics, through behavioral and psychological interventions, have been designed to have a direct impact on the chronic clinical conditions by providing motivational support and encouraging patients to make better lifestyle choices. Such therapeutics are available in a variety of gaming solutions, standalone software applications or combinations of the aforementioned solutions with personal coaching support, artificial intelligence (AI) support and medical device(s).

A number of digital therapeutics have already been marketed and a significant proportion of such candidate therapies are in R&D phase. In order to introduce such unconventional products into the market, companies have followed multiple approaches, which include both B2B and B2C variants. It is also worth highlighting that certain companies are even attempting to offer reimbursements for their proprietary products by conducting clinical trials in order to establish therapeutic credibility and convince insurance providers and payers.

Significant advancements have also been made towards the development of novel solutions for remote monitoring and diagnosis of chronic disorders. Such solutions have been developed to provide healthcare assistance in real-time through smartphone applications and connected devices. These solutions vary significantly in complexity and range from simple solutions capable of tracking weight loss, blood pressure, body temperature and heart rate to more sophisticated solutions that are equipped to independently conduct blood tests to confirm the presence of a bacterial / viral infection.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the market. Based on multiple parameters, such as prices of digital solutions, indication / region specific adoption trends, distribution channels and competitive landscape, we have provided an informed estimate on the likely evolution of digital therapeutics and digital monitoring / diagnostic solutions till 2030.

In order to account for the uncertainties associated with the development of digital therapeutics and novel diagnostic / monitoring solutions and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market's evolution.

Key Topics Covered:

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Digitization in Healthcare Sector
3.2. Next-Generation Healthcare Solutions
3.3. Key Concepts Associated with Digital Health Solutions
3.3.1. Cognitive Behavioral Therapy
3.3.2. Internet of Things
3.3.3. Big Data
3.3.4. Artificial Intelligence
3.3.5. Gamification
3.4. An Overview of Digital Therapeutics
3.4.1. Key Strategic Initiatives
3.4.1.1. Digital Therapeutics Alliance
3.4.1.2. Personal Connected Health Alliance
3.4.1.3. Programs Initiated by The Centers for Disease Control and Prevention
3.4.1.4. HIPAA Act
3.4.1.5. National Health Service Guidelines
3.4.1.6. USFDA Regulations for Digital Therapeutics
3.4.2. Typical Development and Commercialization Pathway for Digital Therapeutics
3.4.2.1. Discovery and Preclinical Phase
3.4.2.2. Clinical Trials and Validation
3.4.2.3. Negotiation with Insurance Providers / Payers
3.4.2.4. Distribution and Marketing
3.4.3. Rising Popularity of Digital Therapeutics
3.5. Remote Digital Monitoring and Diagnosis

4. CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Digital Therapeutics: Overall Market Landscape
4.3. Digital Monitoring / Diagnostic Solutions: Overall Market Landscape

5. DIGITAL THERAPEUTICS: COMPANY PROFILES
5.1. Chapter Overview
5.2. 2Morrow
5.3. Akili Interactive
5.4. Canary Health
5.5 Floreo
5.6. Omada Health
5.7. Pear Therapeutics
5.8. Vida Health
5.9. WellDoc
5.10. Wellthy Therapeutics

6. DIGITAL MONITORING / DIAGNOSTIC SOLUTIONS: COMPANY PROFILES
6.1. Chapter Overview
6.2. AliveCor
6.3. BioSerenity
6.4. Cue
6.5. Kinsa
6.6. Voluntis

7. KEY INSIGHTS: PRODUCT COMPETITIVENESS ANALYSIS AND MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Key Therapeutic Areas
7.2.1. Metabolic Disorders
7.2.2. Mental Health Problems
7.2.3. Neurological Disorders
7.2.4. Other Therapeutic Areas

8. DIGITAL THERAPEUTICS: CLINICAL RESEARCH EVIDENCE
8.1. Chapter Overview
8.2. Digital Therapeutics: Clinical Trials Data
8.3. Digital Therapeutics: Clinical Trials Data: Distribution by Therapeutic Areas
8.4. Digital Therapeutics: Clinical End-Points Analysis: Metabolic Disorders

9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. Digital Therapeutics: Funding and Investment Analysis
9.3.1. Analysis by Number of Funding Instances
9.3.2. Analysis by Amount Invested
9.3.3. Analysis by Type of Funding
9.3.4. Most Active Players in terms of Number of Instances
9.3.5. Most Active Players in terms of Amount of Funding
9.3.6. Most Active Investors in terms of Number of Instances
9.4. Digital Monitoring / Diagnostic Solutions: Funding and Investment Analysis
9.4.1. Analysis by Number of Funding Instances
9.4.2. Analysis by Amount Invested
9.4.3. Analysis by Type of Funding
9.4.4. Most Active Players in terms of Number of Instances
9.4.5. Most Active Players in terms of Amount of Funding
9.4.6. Most Active Investors in terms of Number of Instances

10. COLLABORATIONS AND PARTNERSHIPS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Digital Therapeutics and Monitoring / Diagnostic Solutions: Recent Collaborations and Partnerships
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Most Active Players

11. GO-TO-MARKET STRATEGY
11.1. Chapter Overview
11.2. Digital Therapeutic Developers: Marketing Strategies
11.2.1. Participation in Global Events
11.2.2. Marketing on Social Media Platforms
11.2.3. Marketing on Online / Print Media Platforms
11.2.4. Adoption of Different Business Models and Pricing Strategies
11.2.4.1. B2C Business Model
11.2.4.2. B2B Business Model
11.2.4.3. Pricing Strategy
11.2.5. Undertaking Various Promotional Activities
11.3. Concluding Remarks

12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Digital Therapeutics Market, 2018-2030
12.4. Global Digital Therapeutics Market: Distribution by Type of Solution
12.5. Global Digital Therapeutics Market: Distribution by Focus of Solution
12.6. Global Digital Therapeutics Market: Distribution by Purpose of Solution
12.7. Global Digital Therapeutics Market: Distribution by Business Model
12.8. Global Digital Therapeutics Market: Distribution by Geography
12.9. Global Digital Therapeutics Market: Distribution by Therapeutic Area
12.10. Global Digital Monitoring / Diagnostic Solutions Market, 2018-2030
12.11. Global Digital Monitoring / Diagnostic Solutions Market: Distribution by Type of Solution
12.12. Global Digital Monitoring / Diagnostic Solutions Market: Distribution by Business Model
12.13. Global Monitoring / Diagnostic Solutions Market: Distribution by Geography
12.14. Global Monitoring / Diagnostic Solutions Market: Distribution by Therapeutic Area

13. FUTURE OF DIGITAL SOLUTIONS FOR CHRONIC DISEASE MANAGEMENT
13.1. Chapter Overview
13.2. Digital Health Solutions: SWOT Analysis
13.2.1. Strengths
13.2.2. Weaknesses
13.2.3. Opportunities
13.3.4. Threats
13.3. Digital Solutions for Chronic Disorders: Future Opportunities
13.3.1. Increasing Focus on Patient Centric Models
13.3.2. Applicability Across a Variety of Disease Indications
13.3.3. Increasing Emphasis on Real-World Evidence in R&D
13.3.4. Advances in IT and Computing Power to Foster Future Innovation
13.3.5. Rising Future Demand for Digital Solutions
13.4. Concluding Remarks

14. INTERVIEW TRANSCRIPTS
14.1. Chapter Overview
14.2. Adam Kaufman, Chief Executive Officer, Canary Health
14.3. Amelie Janson, Communications Manager, Voluntis
14.4. Prayat Shah, Co-founder and Vice President, Partnerships, and Reshma Nayak Vice President, Marketing and Communications, Wellthy Therapeutics
14.5. Stephanie Tilenius, Co-Founder and Chief Executive Officer, Vida Health
14.6. Vijay Ravindran, Chief Executive Officer, Floreo

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

• 2Morrow
• 3M Ventures
• 500 Startups
• 5AM Ventures
• 7wire Ventures
• Abbott
• AbbVie
• Aberdare Ventures
• Academy of Managed Care Pharmacists
• ACC
• Accel Diagnostics
• Accenture
• Adage Capital Management
• Adams Street Partners
• Advanced Circulatory Systems
• Advancit Capital
• Aetna
• Airbus
• Akili Interactive
• Akron Children's Hospital
• Alexandria Venture Investments
• AliveCor
• Allen & Company
• AltaMed
• AME Cloud Partners
• American Diabetes Association
• American Investment Holdings
• American Society of Mechanical Engineers
• American Telemedicine Association
• Amgen Venture
• Andreessen Horowitz
• Anorak Ventures
• Anteo Diagnostics
• Anyline
• Aperture Venture Partners
• Aplastic Anemia & MDS International Foundation
• Apollo Hospitals
• Apple
• AppliedVR
• Arboretum Ventures
• Areta Health
• Arthritis New Zealand
• Arthro Therapeutics
• Ascensia Diabetes Care
• Ascension's Brighton Center for Recovery
• Aspect Ventures
• Asthma and Allergy Foundation of America
• AstraZeneca
• AT&T
• Athelas
• Baillie Gifford
• Beaumont Hospital
• Becton Dickinson
• Beehive Holdings
• BEENEXT
• BeHealth Solutions
• Beneufit
• Berger & Moore Advisors
• Berklee's Institute for Creative Entrepreneurship
• Bessemer Venture Partners
• Better Therapeutics
• Betterise Health Tech
• Beurer
• Big Health
• Bigfoot Biomedical
• Bigpoint
• Bioepic
• Biomark
• BioSerenity
• BioTrak Therapeutics
• Biotricity
• Bioventures Investors
• Birla Institute of Technology and Science
• bLife
• Bloom Burton
• Blue Mesa Health
• Blue Spark Technologies
• Blueprint Health
• Bodyport
• Boston Medical Center
• Bpifrance Large Venture
• BrainCheck
• Breyer Capital
• Bridge Builders Collaborative
• Broadway Video Ventures
• Brooklands Capital Strategies
• Burrill & Company
• Burston
• C. Illies
• Caffeinated Capital
• California HealthCare Foundation
• Cambia Health Solutions
• Canaan Partners
• Canary Foundation
• Canary Health
• Cancer Research Collaboration (CRC)
• Canepa Advanced Healthcare Fund
• Canvas Ventures
• CapDecisif Management
• Capricorn ICT Arkiv
• CareFirst
• Carrot Health
• Castlight Health
• Cavendish Global
• CAVU Venture Partners
• Cedars-Sinai Medical Center
• Celebrate the Children
• CellScope
• Center for Autism Research (CAR)
• Center for Managing Chronic Disease, University of Michigan
• Center for the Advancement of Science in Space
• Central Illinois Angels
• Centria Healthcare Autism Services
• Chicago Ventures
• Children's Hospital of Philadelphia
• Cigna
• CIS Agriferts
• Civilization Ventures
• Claritas MindSciences
• Click Therapeutics
• 121 CM-CIC Innovation
• Colgate-Palmolive
• COLOPL VR Fund
• Columbia University Medical Center
• Community College System of New Hampshire
• Connecticut Innovations
• CoreHealth Technologies
• Correlation Ventures
• COWEN
• CPS Capital Group
• CRCM Ventures
• Creandum
• Cue
• Currae Healthtech
• Cyrcadia Health
• DAK-Gesundheit
• Dartmouth College
• Data Collective
• Dataiku
• DCM
• Deerfield Management
• Delivering Scientific Innovation for Autism
• Dendera Ventures
• Dentsu Ventures
• Department of Veteran Affairs
• Dermal Clinic
• Dexcom
• Diasend
• Digitalis
• Digithera
• dLife
• Draper Fisher Jurvetson
• dRx Capital
• Dthera Sciences
• Echo Health Ventures
• eClinical Works
• Eco-Fusion
• EDBI
• Elevation Capital
• Ellume
• Emory University
• Empatica
• Empire Capital Partners
• Endeavor Catalyst
• Endotronix
• Essex Woodlands
• European School on Interdisciplinary Tinnitus Research
• Eva Ventures
• Excel Venture Management
• Facebook
• Felicis Ventures
• FireStarter Fund
• FirstMark Capital
• Fit4D
• FitBit
• Flare Capital Partners
• Flatiron Investors
• Floodgate
• Floreo
• Florida Hospital
• Flying Health
• Force Over Mass Capital
• Ford Motor Company
• Forward Partners
• Founder Collective
• Founders Fund
• Fred Hutchinson Cancer Research Center
• Freelands Ventures
• Fruit Street
• Fuerst Technology Innovations
• GAIA
• GC VR Tracker Fund
• GE Ventures
• Genentech
• General Catalyst
• George Washington University School of Medicine
• Georgian Partners
• GlaxoSmithKline
• Global to Local
• Glooko
• GluSense
• GNS Healthcare
• Greycroft
• GrowX Venture Management
• GSR Ventures
• Hanmi IT
• Harbor Pacific Capital
• Harrison Metal
• Health Care Originals
• HealthReveal
• HealthSlate
• HealthTap
• HealthX Ventures
• Healthy Trucking Association of America
• Heart Foundation
• HelloFresh
• Highmark Health
• High-Tech Grnderfonds
• Hikma Ventures
• Hint
• Hintsa Performance
• Hospices Civils de Lyon
• Hudson River Capital Partners
• Human API
• Humana
• Hyde Park Angels
• I2A Fund
• iBionext
• IBM
• Idinvest Partners
• IEEE
• iHealth Lab
• IIFL Select Equity Fund
• i-Mercury Capital
• Immortalana
• iMotions
• Impact First Investments
• Incos Invest
• Index Ventures
• Initialized Capital
• Innogest Capital
• INNOTHERA
• Innovate Health Tech NYC
• Innovation Capital
• Innovation Works
• Innovationsstarter Fonds Hamburg
• Institut de la Vision
• Insulet
• Intel Capital
• Intermountain Healthcare
• International Finance Corporation (IFC)
• InterVest
• Invitalia Ventures
• iSeed Ventures
• iSono Health
• Israel Innovation Authority
• Itochu
• JamJar Investments
• Janssen Research & Development
• JAZZ Venture Partners
• Jett Capital Advisors
• John P. McGovern Museum of Health and Medical Science
• Johns Hopkins School of Hygiene and Public Health
• Johnson & Johnson Innovation
• Joslin Diabetes Center
• Joyable
• Jumpstart Ventures
• Juvenile Diabetes Research Foundation T1D fund
• Kaia Health
• Kaiser Permanente Ventures
• Kapor Capital
• Karuna Labs
• Khosla Ventures
• King's College London
• Kinnevik
• Kinsa
• Kleiner Perkins Caufield & Byers
• Kurbo Health
• Kurma Diagnostics
• Kyma Medical Technologies
• Landmark Benefits
• Lark Health
• LB Investment
• LBO France
• Leman Micro Devices
• LEO Innovation Lab
• Lief Therapeutics
• Life Sciences Discovery Fund
• LifeForce Capital
• Lifeforce Ventures
• Lifeline Biotechnologies
• Lifeline Ventures
• LifeScan
• Lifespot Health
• LifeWatch
• LifeWave Biomedical
• Lightspeed Venture Partners
• LindaCare
• LinkedIn
• Liquid 2 Ventures
• Livongo Health
• Louisiana Department of Health
• Lumira Capital
• Lund University
• Lux Capital
• M Ventures
• M12
• m8 Capital
• Magellan Health
• Manipal Education & Medical Group
• MAP Health Management
• Maryland Technology Development Corporation (TEDCO)
• Massachusetts General Hospital
• Max Healthcare
• Mayfield Fund
• Mayo Clinic
• Medelinked
• Medtronic
• Melon Health
• Merck
• Meru Health
• mHealth Technologies
• Mid-Atlantic Telehealth Resource Center
• Millar
• Ministry of Health, Manatu Hauora
• MIT Hacking Medicine
• Mobio Technologies
• Montage Ventures
• Murray-Bertron
• mySugr
• Naluri Hidup
• Nanobiosym Diagnostics
• Nanon
• NantHealth
• National Aeronautics and Space Administration
• National Cancer Institute
• National Institute of Biomedical Imaging and Bioengineering
• National Institute of Diabetes and Digestive and Kidney Diseases
• National Institute of Mental Health and Neuro Sciences
• National Institute on Drug Abuse (NIDA)
• National Institutes of Health
• National Multiple Sclerosis Society
• Nemaura Medical
• NeuroCure
• NeuroMetrix
• Neurotrack
• New Enterprise Associates
• New Mexico Retiree Health Care Authority (NMRHCA)
• New World Ventures
• Newtopia
• Nexeon MedSystems
• Nike
• Nimbus Synergies
• NODEHealth
• Nokia Growth Partners
• Noom
• North Texas Angel Network
• North York General Hospital
• Northwell Ventures
• Norwest Venture Partners
• Norwich Ventures
• Novant Health
• Novartis
• Novo Nordisk
• Nueon
• Nutrino
• Obvious Ventures
• Octopus Ventures
• Oklahoma Life Science Fund
• Omada Health
• Omega Diagnostics
• Omron Healthcare
• Oncology Care Home Health
• Onduo
• Ontario Telemedicine Network
• Open Medicine Institute
• Oracle
• OSF Ventures
• Otsuka Pharmaceutical
• Oxford Academic Health Science Network
• Oxford Finance
• Pallasite Ventures
• Palo Alto Medical Foundation
• Parasail Health
• Partners in Health
• PatientsLikeMe
• Pear Therapeutics
• Personal Health Solutions
• Pfizer
• Philips
• Pierre Fabre
• Pinterest
• Pittsburgh Life Sciences Greenhouse
• Pixie Scientific
• Playground Global
• PMV
• Podimetrics
• POPS! Diabetes Care
• Premera Blue Cross
• Presence Capital
• Prestige Health Choice
• Preventice Solutions
• Pritzker Group Venture Capital
• Profil Institute
• Promus Ventures
• Propeller Health
• Proteus Digital Health
• Provenance Venture Forum
• Providence Health & Services
• Purdue University
• PureTech Health
• Qardio
• Qiming Venture Partners
• Qualcomm Ventures
• Quinze-Vingts National Ophthalmology Hospital
• Quotas Beteiligungs
• R7 Partners
• RB Investments
• Reaktor Ventures
• Real Appeal
• Recruit Strategic Partners
• RedBrick Health
• Redmile Group
• Reflectance Medical
• ResApp Health
• Research Foundation for The State University of New York
• Research Society for The Study of Diabetes in India (RSSDI)
• Restore Health
• Rethink Impact
• Retina Foundation of the Southwest
• Retrofit
• Revon Systems
• Rewire
• Roche
• Rock Health
• R-Pharm
• RRE Ventures
• Rwandan Ministry of Health & National Reference Laboratory
• Rx.Health
• S.R. One
• Safeguard Scientifics
• Samsung
• Sandoz
• Sanitas
• Sano Intelligence
• Sanofi
• Sapphire Ventures
• Schoolhouse Partners
• SciFi VC
• Scrum Ventures
• Selfridges
• Sennheiser
• Sequoia Capital
• Servier
• ShapeUp
• Sherpa Capital
• Shire
• Signia Venture Partners
• Silicon Valley Bank
• Sino Portfolio International
• Siren Care
• Slow Ventures
• Social Capital
• Solera Health
• Somatix
• Sonormed
• SOS Ventures
• Sozo Ventures
• Sparo
• Spectrum Equity
• Spire
• SportsWareOnLine
• Spotify
• Spring Ridge Ventures
• St. Joseph's Care Group
• St. Jude Medical
• St. Luke's Health System
• St. Michael's Hospital
• STADA
• Stanford University
• Stanley Park Ventures
• Startup Funding Club
• StartUp Health
• Steelcase
• Sunovion Pharmaceuticals
• Sutter Health
• SV Life Sciences
• Sweet Capital
• Swiss Re
• Synovation Medical Group
• Tactio Health Group
• Teladoc
• Telcare
• Telefonica
• Temasek Holdings
• The Carlyle Group
• The Chernin Group
• The Robotics Hub
• The Sync Project
• The Valley Fund
• The Venture Reality Fund
• The Vertical Group
• Thrive Capital
• Tilak Healthcare
• Tower Capital Partners
• TransLink Capital
• TreeHouse Health
• TriplePoint Capital
• True Ventures
• True Wealth Ventures
• Turnaround Health
• Twine Health
• Twitter
• U.S. Venture Partners
• uHealth Australia
• Uncork Capital
• UniQuest
• United Healthcare
• University Hospitals Leuven (UZ Leuven)
• University Medical Center Goettingen
• University of Bern
• University of Calgary
• University of California San Francisco
• University of Hamburg
• University of London
• University of Lubeck
• University of Maryland
• University of Massachusetts Medical School
• University of Michigan
• University of Missouri
• University of Nebraska
• University of North Carolina
• University of Oxford
• University of Queensland
• University of Rochester
• University of Texas at Dallas
• University of Texas Southwestern Medical School
• University of Washington
• UPMC Enterprises
• Valeritas Holdings
• Vanguard Medical Group
• Venrock
• Verily Life Sciences
• Vertical Group
• Vesalius Biocapital Partners
• Vheda Health
• Vida Health
• Vimeo
• Virgin Atlantic
• Virta Health
• VirtualScopics
• Vital Art and Science
• Vivid Vision
• VNR Vignana Jyothi Institute of Engineering and Technology
• Voluntis
• Wake Forest University
• Wanxiang America
• Washington University School of Medicine
• Welkin Health
• WellDoc
• Wellthy Therapeutics
• Welltrinsic Sleep Network
• West Coast Primary Health Organization
• William Morris Endeavor
• William Osler Health System
• Windham Venture Partners
• Withings
• Workit Health
• World Health Organization
• XING
• Xtreme Labs
• Y Combinator
• Yale University
• YPSOMED
• Zaffre Investments
• Zoll Medical
  

For more information about this report visit https://www.researchandmarkets.com/research/ng48gw/digital_health?w=12